Neonatal Respiratory Distress Syndrome Treatment Global Market Report 2025
상품코드:1717251
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
신생아 호흡곤란 증후군 치료 시장 규모는 향후 수년간 강력한 성장세를 보일 것으로 예상되며, 2029년에는 CAGR 8.0%로 14억 1,000만 달러에 달할 것으로 예측됩니다. 예측 기간 중의 성장은 액세서리 및 소모품에 대한 수요 증가, NICU 입실 증가, 맞춤형 의료에 대한 요구 증가, 조산율 증가, R&D 활동 확대 등의 요인에 기인합니다. 예측 기간 중 예상되는 주요 동향으로는 신생아 중환자실(NICU)의 자동화, 인공지능(AI) 통합, 신생아 관리 기술의 발전, 계면활성제 치료의 혁신, 첨단 인공호흡기 기술 개발 등이 있습니다.
조산 증가로 신생아 호흡곤란 증후군(NRDS) 치료제 시장이 확대될 것으로 예측됩니다. 조산은 아기가 임신 37주 미만으로 태어날 때 발생하며, 일반적인 임신 기간은 약 40주이므로 32주 미만으로 태어난 아기는 가장 큰 건강 위험에 직면하게 됩니다. 조산 증가는 모체 연령 증가, 다태 임신, 병력, 생활습관 선택, 불임 치료, 감염, 환경적 영향 등의 요인에 기인합니다. 신생아 호흡곤란 증후군은 미숙아에게 많이 나타나는데, 폐가 미숙하고 계면활성제 생산이 불충분하기 때문입니다. 신생아 호흡곤란 증후군의 치료는 폐 기능을 개선하고 호흡을 안정시키며 조산아의 호흡 부전 위험을 낮추는 데 도움이 됩니다. 예를 들어 영국에 기반을 둔 자선 단체인 Tommy's는 2022년 12월에 잉글랜드와 웨일즈의 미숙아 비율이 2021년 7.5%에서 2022년 7.9%로 증가하여 2년 연속 미숙아가 증가하여 그 해 미숙아 수가 5만 3,000명을 넘어섰다고 보고했습니다. 결과적으로 미숙아 출산 증가는 NRDS 치료 시장의 성장에 박차를 가하고 있습니다.
신생아 호흡곤란 증후군 치료 시장의 주요 기업은 산소화를 개선하고, 호흡 합병증을 줄이고, 저산소성 호흡부전 신생아에게 비침습적 치료 옵션을 제공하기 위해 일산화질소 발생기와 같은 첨단 기술 개발에 주력하고 있습니다. 일산화질소 발생기는 일산화질소 가스를 발생 및 투여하는 장비로, 특히 신생아 및 중증 환자에서 산소화를 촉진하고 폐 고혈압을 감소시켜 호흡기 질환을 치료하는 데 사용됩니다. 예를 들어 2022년 6월 미국의 의료기기 및 바이오 제약 회사인 비욘드 에어(Beyond Air)는 자사의 랭핏 PH(Langfit PH)에 대한 FDA 승인을 받았습니다. 이 혁신적인 일산화질소 발생기는 신생아 지속성 폐고혈압증(PPHN)을 포함한 저산소성 호흡부전 신생아 및 신생아에 가까운 신생아를 치료하기 위해 고안되었습니다. 이 장비는 비욘드 에어의 특허 기술인 이오나이저 기술을 활용해 주변 공기에서 온디맨드 방식으로 일산화질소를 생성하므로 용량이나 유량에 구애받지 않고 지속적으로 공급할 수 있습니다. 또한 저전력 컴프레서를 사용하여 질소와 산소를 이온화하여 이산화질소(NO2) 발생을 최소화하고, 스마트 필터를 사용하여 안전하게 여과합니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나바이러스의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 신생아 호흡곤란 증후군 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 신생아 호흡곤란 증후군 치료 시장 : 성장률 분석
세계의 신생아 호흡곤란 증후군 치료 시장 실적 : 규모와 성장, 2019-2024
세계의 신생아 호흡곤란 증후군 치료 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 신생아 호흡곤란 증후군 치료 TAM(Total Addressable Market)
제6장 시장 세분화
세계의 신생아 호흡곤란 증후군 치료 시장 : 테라피별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
산소 요법
계면활성제 요법
세계의 신생아 호흡곤란 증후군 치료 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
비경구
흡입
기타 투여 경로
세계의 신생아 호흡곤란 증후군 치료 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
아급성기 시설
홈케어
소매 약국
세계의 신생아 호흡곤란 증후군 치료 시장, 산소 요법의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
기존 산소 요법
고유량 비강 캐뉼라(HFNC) 산소 요법
지속적 양압호흡(CPAP) 산소 요법
산소 요법을 수반하는 침습적 인공 호흡
세계의 신생아 호흡곤란 증후군 치료 시장, 계면활성제 요법의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
천연 계면활성제
합성 계면활성제
복합 계면활성제 요법(천연＋합성)
예방적 계면활성제 요법
구조 계면활성제 요법
제7장 지역별·국가별 분석
세계의 신생아 호흡곤란 증후군 치료 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 신생아 호흡곤란 증후군 치료 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
신생아 호흡곤란 증후군 치료 시장 : 경쟁 구도
신생아 호흡곤란 증후군 치료 시장 : 기업 개요
Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
Bayer AG Overview, Products and Services, Strategy and Financial Analysis
Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
Medline Industries
Becton Dickinson
Stryker Corporation
GE Healthcare
Koninklijke Philips NV
ResMed Inc.
Dragerwerk AG & Co. KGaA
Chiesi Farmaceutici
ICU Medical Inc.
Fisher & Paykel Healthcare
Vyaire Medical
Laerdal Medical
Hamilton Medical
Inspiration Healthcare
Ventec Life Systems
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
신생아 호흡곤란 증후군 치료 시장 2029 : 새로운 기회를 제공하는 국가
신생아 호흡곤란 증후군 치료 시장 2029 : 새로운 기회를 제공하는 부문
신생아 호흡곤란 증후군 치료 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁의 전략
제36장 부록
KSA
영문 목차
영문목차
Neonatal respiratory distress syndrome (NRDS) treatment focuses on managing premature infants who experience breathing difficulties due to inadequate surfactant production. This treatment typically includes the administration of exogenous surfactant therapy, respiratory support through mechanical ventilation or continuous positive airway pressure (CPAP), and oxygen supplementation.
The primary treatments for neonatal respiratory distress syndrome are oxygen therapy and surfactant therapy. Oxygen therapy involves supplying oxygen to patients who struggle to get enough oxygen through normal breathing. It can be delivered via parenteral routes, inhalation, or other methods, and is used in hospitals, sub-acute facilities, home care settings, and retail pharmacies.
The neonatal respiratory distress syndrome treatment market research report is one of a series of new reports from The Business Research Company that provides neonatal respiratory distress syndrome treatment market statistics, including neonatal respiratory distress syndrome treatment industry global market size, regional shares, competitors with a neonatal respiratory distress syndrome treatment market share, detailed neonatal respiratory distress syndrome treatment market segments, market trends and opportunities, and any further data you may need to thrive in the neonatal respiratory distress syndrome treatment industry. This neonatal respiratory distress syndrome treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The neonatal respiratory distress syndrome treatment market size has grown strongly in recent years. It will grow from $0.96 billion in 2024 to $1.03 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth during the historic period can be attributed to factors such as the rising permeability and fluid accumulation in the alveoli, an increase in alveolar-capillary permeability, a higher utilization of mechanical ventilation, greater awareness among healthcare providers and parents about the importance of neonatal care, and increased investments in healthcare.
The neonatal respiratory distress syndrome treatment market size is expected to see strong growth in the next few years. It will grow to $1.41 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth during the forecast period can be attributed to factors such as the rising demand for accessories and consumables, an increase in NICU admissions, a growing need for personalized medicine, a higher rate of premature births, and expanding research and development activities. Key trends expected in the forecast period include the automation of neonatal intensive care units (NICUs), the integration of artificial intelligence (AI), advancements in neonatal care technology, innovations in surfactant therapy, and the development of advanced ventilator technologies.
The growing incidence of premature births is expected to drive the expansion of the neonatal respiratory distress syndrome (NRDS) treatment market. Premature birth, or preterm birth, occurs when a baby is born before 37 weeks of pregnancy, with those born before 32 weeks facing the greatest health risks, as a typical pregnancy lasts about 40 weeks. The rise in premature births is attributed to factors such as advancing maternal age, multiple pregnancies, medical conditions, lifestyle choices, fertility treatments, infections, and environmental influences. Neonatal respiratory distress syndrome is commonly seen in premature infants due to their underdeveloped lungs and insufficient surfactant production. Treatment for NRDS helps improve lung function, stabilize breathing, and lower the risk of respiratory failure in preterm babies. For example, Tommy's, a UK-based charity, reported in December 2022 that the percentage of premature live births in England and Wales increased to 7.9% in 2022 from 7.5% in 2021, marking a second consecutive year of rising premature births, with over 53,000 babies born prematurely that year. As a result, the growing incidence of premature births is fueling the growth of the NRDS treatment market.
Leading companies in the neonatal respiratory distress syndrome treatment market are focusing on the development of advanced technologies such as nitric oxide generators to improve oxygenation, reduce respiratory complications, and provide non-invasive treatment options for neonates with hypoxic respiratory failure. A nitric oxide generator is a device that produces and administers nitric oxide gas, which is used to treat respiratory issues by enhancing oxygenation and reducing pulmonary hypertension, especially in neonates and critically ill patients. For example, in June 2022, Beyond Air Inc., a US-based medical device and biopharmaceutical company, received FDA approval for its LungFit PH. This innovative nitric oxide generator is designed to treat term and near-term neonates with hypoxic respiratory failure, including persistent pulmonary hypertension of the newborn (PPHN). The device utilizes Beyond Air's patented Ionizer technology to generate nitric oxide on demand from ambient air, providing a continuous supply without concerns about dosage or flow. It also uses a low-power compressor to ionize nitrogen and oxygen, minimizing the production of nitrogen dioxide (NO2), which is then safely filtered out using a smart filter.
In January 2024, Chiesi Group, an Italy-based biopharmaceutical company, entered into a partnership with Oak Hill Bio to advance neonatal therapies. This collaboration aims to develop and commercialize OHB-607, an innovative treatment designed to prevent severe bronchopulmonary dysplasia (BPD) and its long-term respiratory complications in preterm infants, especially those born before 28 weeks gestational age with low IGF-1 levels. Oak Hill Bio is a UK-based company focused on developing treatments for neonatal and rare diseases.
Major players in the neonatal respiratory distress syndrome treatment market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Abbott Laboratories, Medtronic Plc, Medline Industries, Becton Dickinson, Stryker Corporation, GE Healthcare, Koninklijke Philips NV, ResMed Inc., Dragerwerk AG & Co. KGaA, Chiesi Farmaceutici, ICU Medical Inc., Fisher & Paykel Healthcare, Vyaire Medical, Laerdal Medical, Hamilton Medical, Inspiration Healthcare, Ventec Life Systems, Neotech Products, Aerogen Pharma Corp., Windtree Therapeutics Inc., Discovery Laboratories Inc., and Lyomark Pharma GmbH.
North America was the largest region in the neonatal respiratory distress syndrome treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neonatal respiratory distress syndrome treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the neonatal respiratory distress syndrome treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The neonatal respiratory distress syndrome treatment market consists of revenues earned by entities by providing services such as surfactant administration services, neonatal respiratory care consulting, telemedicine, and remote monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The neonatal respiratory distress syndrome treatment market also includes sales of mechanical ventilators, continuous positive airway pressure (CPAP) machines, high-frequency ventilators, and neonatal incubators. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Neonatal Respiratory Distress Syndrome Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on neonatal respiratory distress syndrome treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for neonatal respiratory distress syndrome treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neonatal respiratory distress syndrome treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Therapy: Oxygen Therapy; Surfactant Therapy
2) By Route Of Administration: Parenteral; Inhalation; Other Routes Of Administration
3) By End User: Hospitals; Sub-Acute Facilities; Home Care; Retail Pharmacies
3. Neonatal Respiratory Distress Syndrome Treatment Market Trends And Strategies
4. Neonatal Respiratory Distress Syndrome Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Neonatal Respiratory Distress Syndrome Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Neonatal Respiratory Distress Syndrome Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.1. Global Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oxygen Therapy
Surfactant Therapy
6.2. Global Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Parenteral
Inhalation
Other Routes Of Administration
6.3. Global Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Sub-Acute Facilities
Home Care
Retail Pharmacies
6.4. Global Neonatal Respiratory Distress Syndrome Treatment Market, Sub-Segmentation Of Oxygen Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Neonatal Respiratory Distress Syndrome Treatment Market
9.1. China Neonatal Respiratory Distress Syndrome Treatment Market Overview
9.2. China Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Neonatal Respiratory Distress Syndrome Treatment Market
10.1. India Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Neonatal Respiratory Distress Syndrome Treatment Market
11.1. Japan Neonatal Respiratory Distress Syndrome Treatment Market Overview
11.2. Japan Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Neonatal Respiratory Distress Syndrome Treatment Market
12.1. Australia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Neonatal Respiratory Distress Syndrome Treatment Market
13.1. Indonesia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Neonatal Respiratory Distress Syndrome Treatment Market
14.1. South Korea Neonatal Respiratory Distress Syndrome Treatment Market Overview
14.2. South Korea Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Neonatal Respiratory Distress Syndrome Treatment Market
15.1. Western Europe Neonatal Respiratory Distress Syndrome Treatment Market Overview
15.2. Western Europe Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Neonatal Respiratory Distress Syndrome Treatment Market
16.1. UK Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.1. Germany Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Neonatal Respiratory Distress Syndrome Treatment Market
18.1. France Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.1. Spain Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Neonatal Respiratory Distress Syndrome Treatment Market
21.1. Eastern Europe Neonatal Respiratory Distress Syndrome Treatment Market Overview
21.2. Eastern Europe Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Neonatal Respiratory Distress Syndrome Treatment Market
22.1. Russia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Neonatal Respiratory Distress Syndrome Treatment Market
23.1. North America Neonatal Respiratory Distress Syndrome Treatment Market Overview
23.2. North America Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Neonatal Respiratory Distress Syndrome Treatment Market
24.1. USA Neonatal Respiratory Distress Syndrome Treatment Market Overview
24.2. USA Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Neonatal Respiratory Distress Syndrome Treatment Market
26.1. South America Neonatal Respiratory Distress Syndrome Treatment Market Overview
26.2. South America Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Neonatal Respiratory Distress Syndrome Treatment Market
27.1. Brazil Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Neonatal Respiratory Distress Syndrome Treatment Market
28.1. Middle East Neonatal Respiratory Distress Syndrome Treatment Market Overview
28.2. Middle East Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Neonatal Respiratory Distress Syndrome Treatment Market
29.1. Africa Neonatal Respiratory Distress Syndrome Treatment Market Overview
29.2. Africa Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Neonatal Respiratory Distress Syndrome Treatment Market Competitive Landscape And Company Profiles
